논문 검색
검색 결과: 7,487건 SQL fulltext · 📖 OA 100% ›
-
activates histone lactylation to promote gastric cancer progression and immune evasion through the HAS2/c-MYC/PD-L1 axis.
[BACKGROUND] Metabolic reprogramming and epigenetic alterations play important roles in driving tumor microenvironment (TME) remodeling and immune evasion in gastric cancer (GC). Histone lactylation links glycolytic metabolism to transcript…
FULLTEXT: Metabolic Reprogramming -
An exploratory serum metabolomics study for screening and staging of breast cancer.
[OBJECTIVE] This study investigates serum metabolic profiles in breast cancer to identify diagnostic biomarkers and stage-specific metabolites, offering insights for clinical practice. [METHODS] Gas chromatography‒mass spectrometry (GC‒MS)…
FULLTEXT: Metabolic Reprogramming -
Endometrial receptivity in polycystic ovary syndrome: altered biomarkers and underlying mechanisms.
Polycystic ovary syndrome (PCOS) is a common endocrine disorder characterized by hyperandrogenism and ovulatory dysfunction. Women with PCOS are at an increased risk for adverse pregnancy outcomes, such as miscarriage and preterm birth. End…
FULLTEXT: Metabolic Reprogramming -
The role of copper and cuproptosis in digestive system cancers: novel therapeutic strategies and mechanistic insights.
Recent research has highlighted the critical role of copper metabolism and a novel form of copper-dependent cell death, termed cuproptosis, in the progression and treatment of these cancers. Copper, an essential trace element, plays a cruci…
FULLTEXT: Metabolic Reprogramming -
Microbiota as a modulator of drug response: targeting microbial-drug crosstalk in cancer therapy.
In recent years, accumulating evidence has established mechanistic connections between the microbiota and the efficacy of anticancer treatments, encompassing microbial communities residing in the gut, within tumors, and across other tissue …
FULLTEXT: Metabolic Reprogramming -
Leukemia-derived exosomes induce immunosuppression of dendritic cell function via TGFB2-MRPL58 axis.
[OBJECTIVES] To elucidate the mechanisms by which leukemia-derived exosomes induce immunosuppression in dendritic cells (DCs) and identify potential therapeutic targets. [METHODS] The optimal exosome dosage (20 µg/ml) for DC treatment was …
FULLTEXT: Metabolic Reprogramming -
NAD precursor supplementation reverses CD36-mediated lipid accumulation and ferroptosis to restore antitumor function of NK cells in DLBCL.
Natural killer (NK) cells play a key role in the standard treatment of diffuse large B-cell lymphoma (DLBCL). However, NK cells in DLBCL patients frequently display an exhausted phenotype, which is associated with poor clinical outcomes. Th…
FULLTEXT: Metabolic Reprogramming -
The role of mesencephalic astrocyte-derived neurotrophic factor in digestive diseases.
[BACKGROUND] Mesencephalic astrocyte-derived neurotrophic factor (MANF) is an evolutionarily conserved endoplasmic reticulum (ER)-resident and secreted protein highly expressed in the digestive system. Emerging evidence has highlighted its …
FULLTEXT: Metabolic Reprogramming -
Absence of steatosis combined with cardiometabolic risk factors confers the highest hepatocellular carcinoma risk in treated chronic hepatitis B.
[BACKGROUND] Chronic hepatitis B (CHB) is a major cause of hepatocellular carcinoma (HCC). In patients receiving CHB treatment, coexistence of steatotic liver disease (SLD) and cardiometabolic risk factors (CMRFs) markedly influence HCC ris…
FULLTEXT: Metabolic Reprogramming -
Targeting FMO3 suppresses the malignant phenotype of colorectal cancer: evidence from bioinformatics to functional experiments.
[AIMS] Flavin-containing monooxygenase 3 (FMO3) is a key metabolic enzyme involved in endogenous metabolism; however, its role in colorectal cancer (CRC) remains poorly understood. This study aimed to investigate the expression pattern, bio…
FULLTEXT: Metabolic Reprogramming -
Discovery of novel and highly potent XIAP-targeted peptide inhibitors using virtual screening.
Lung cancer, a globally prevalent fatal malignancy, remains a major therapeutic challenge. X-linked inhibitor of apoptosis protein (XIAP) is overexpressed in various cancers, driving uncontrolled proliferation, while its specific inhibition…
FULLTEXT: Metabolic Reprogramming -
Associations of breast DNA methylation-based measures of biological ageing with obesity-related breast cancer risk markers.
Advancing age and deregulated obesity are well-established risk factors for breast cancer risk. While epigenetic ageing, a measure of biological ageing, has been linked to breast cancer risk, prior studies have mainly focused on blood-based…
FULLTEXT: Metabolic Reprogramming -
Beyond translation: systematic insight of the multifaceted roles of GARS1 in cellular biology and disease.
Human glycyl-tRNA synthetase (GARS), encoded by the GARS1 gene, is a key protein within the aminoacyl-tRNA synthetases family, responsible for catalyzing the attachment of glycine to its corresponding tRNA during protein synthesis. While am…
FULLTEXT: Metabolic Reprogramming -
Systematic meta-analysis of the toxicities and side effects of the targeted drug lenvatinib.
[BACKGROUND] Lenvatinib, an effective targeted drug for various cancers, has clinical medication safety concerns due to its toxicities and side effects. [OBJECTIVE] This study evaluated lenvatinib-induced any adverse events (any AEs) and n…
FULLTEXT: Metabolic Reprogramming -
Research progress of ferroptosis in cervical cancer treatment.
: Ferroptosis, an iron-dependent form of regulated cell death driven by lipid peroxidation, has recently emerged as a promising therapeutic strategy for cervical cancer, particularly in tumors resistant to conventional radiotherapy and chem…
FULLTEXT: Metabolic Reprogramming -
The gut microbiota-obesity axis in the pathogenesis and prognosis of breast cancer.
[BACKGROUND] Breast cancer (BC) remains a major global health concern, accounting for 11.7% of all cancer cases and ranking as the second leading cause of female cancer-related deaths worldwide. Increasing evidence highlights the interplay …
FULLTEXT: Metabolic Reprogramming -
Risk of adverse events in elotuzumab-treated patients with multiple myeloma: a systematic review and meta-analysis.
[BACKGROUND] Elotuzumab, an anti-SLAMF7 monoclonal antibody for multiple myeloma (MM), lacks a comprehensive safety profile from meta-analysis. [METHODS] We systematically searched PubMed, Web of Science, EMBASE and CENTRAL through Februar…
FULLTEXT: Metabolic Reprogramming -
LDH isozymes as targets for cancer therapy.
The Warburg effect, a hallmark of cancer, positions lactate dehydrogenase (LDH) as a key therapeutic target. Mammals possess three LDH isozymes (LDH-A, LDH-B, LDH-C) with distinct properties. This review critically re-evaluates the simplist…
FULLTEXT: Metabolic Reprogramming -
Application and mechanistic research of novel therapeutic strategies in cisplatin-resistant small cell lung cancer.
[INTRODUCTION] Small cell lung cancer (SCLC) initially responds well to cisplatin-based chemotherapy, but rapid development of drug resistance limits long-term efficacy and subsequent treatment options. Understanding the multifactorial mech…
FULLTEXT: Metabolic Reprogramming -
Therapeutic strategies of metabolic reprogramming in non-small cell lung carcinoma.
[BACKGROUND] Non-small cell lung carcinoma (NSCLC) remains a leading cause of cancer-related mortality worldwide, with existing therapies frequently hindered by drug resistance and immunosuppression. Metabolic reprogramming (glycolysis, lip…
FULLTEXT: Metabolic Reprogramming